Roy Doumani Net Worth & Insider Trades
Roy Doumani - Director, Kite Pharma, Inc
What is Roy Doumani's Net Worth?
The current estimated net worth of Kite Pharma, Inc's Director, Roy Doumani, is estimated to be about $3.48M . Roy Doumani owns about 175,082 units of Kite Pharma, Inc common stock. In the last 2 years at Kite Pharma, Inc, Roy Doumani has sold an estimated value of $35.1M worth.
What is Roy Doumani's Past Insider Trading?
Roy Doumani's largest purchase order was 50,000 units , worth over $67.5K on March 2, 2017. Roy Doumani's largest sale order was 18,800 units , worth over $1.4M on March 2, 2017. In total, Roy Doumani has made about 7 transactions over 2 years of their time at Kite Pharma, Inc. Roy Doumani usually trades in June, with the busiest year in 2017. The most recent transaction was a sale order of 15,000 units , worth over $1.27M on June 9, 2017.
ROY DOUMANI
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What are Kite Pharma, Inc's Past Insider Trades?
Kite Pharma, Inc's most recent insider trade came on September 27, 2017 by Shawn Tomasello who sold 4,203 units worth $755.13K . In the last 2 years, insiders at Kite Pharma, Inc have sold an estimated value of $864.82M and bought an estimated value of $20.6M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Cynthia Butitta, Chief Operating Officer, Jeffrey Wiezorek, SVP Clinical Development, and David Chang, EVP .
Kite Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||